ALDEYRA THERAPEUTICS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ALDEYRA THERAPEUTICS, INC. (ALDX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.18M, a 19.78% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.29M, a 17.24% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $1.47M, a 5.11% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.51M, a 16.10% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $6.01M, a 9.49% decline from fiscal 2024.
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $6.64M, a 2.82% increase from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $6.45M, a 4.41% increase from fiscal 2022.
- ALDEYRA THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $6.18M, a 11.79% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 5 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.18M 10-Q · filed 2026-08-06 | $2.47M 10-Q · filed 2026-08-06 | $3.93M derived: sum of 3 quarters · filed 2026-08-06 | $5.45M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-07 | $2.76M derived: sum of 2 quarters · filed 2026-05-07 | $4.27M derived: sum of 3 quarters · filed 2026-05-07 | $5.74M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.98M derived: sum of 2 quarters · filed 2026-02-27 | $4.45M derived: sum of 3 quarters · filed 2026-08-06 | $6.01M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $1.51M 10-Q · filed 2025-11-05 | $2.98M derived: sum of 2 quarters · filed 2026-08-06 | $4.54M 10-Q · filed 2025-11-05 | $5.93M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $1.47M 10-Q · filed 2026-08-06 | $3.03M 10-Q · filed 2026-08-06 | $4.42M derived: sum of 3 quarters · filed 2026-08-06 | $6.22M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.56M 10-Q · filed 2026-05-07 | $2.95M derived: sum of 2 quarters · filed 2026-05-07 | $4.76M derived: sum of 3 quarters · filed 2026-05-07 | $6.50M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.20M derived: sum of 2 quarters · filed 2026-02-27 | $4.94M derived: sum of 3 quarters · filed 2026-02-27 | $6.64M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.80M 10-Q · filed 2025-11-05 | $3.55M derived: sum of 2 quarters · filed 2025-11-05 | $5.24M 10-Q · filed 2025-11-05 | $6.75M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | $1.75M 10-Q · filed 2025-08-07 | $3.44M 10-Q · filed 2025-08-07 | $4.95M derived: sum of 3 quarters · filed 2025-08-07 | $6.57M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-14 | $3.20M derived: sum of 2 quarters · filed 2025-05-14 | $4.83M derived: sum of 3 quarters · filed 2025-05-14 | $6.45M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.14M derived: sum of 2 quarters · filed 2025-02-28 | $4.76M derived: sum of 3 quarters · filed 2025-02-28 | $6.45M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $1.63M 10-Q · filed 2024-11-07 | $3.25M derived: sum of 2 quarters · filed 2024-11-07 | $4.94M 10-Q · filed 2024-11-07 | $6.48M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $1.62M 10-Q · filed 2024-08-01 | $3.32M 10-Q · filed 2024-08-01 | $4.85M derived: sum of 3 quarters · filed 2024-08-01 | $6.37M derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | $1.69M 10-Q · filed 2024-05-02 | $3.23M derived: sum of 2 quarters · filed 2024-05-02 | $4.75M derived: sum of 3 quarters · filed 2024-05-02 | $6.10M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $3.06M derived: sum of 2 quarters · filed 2024-03-07 | $4.40M derived: sum of 3 quarters · filed 2024-03-07 | $6.18M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $1.52M 10-Q · filed 2023-11-03 | $2.87M derived: sum of 2 quarters · filed 2023-11-03 | $4.65M 10-Q · filed 2023-11-03 | $6.47M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $1.35M 10-Q · filed 2023-08-03 | $3.13M 10-Q · filed 2023-08-03 | $4.95M derived: sum of 3 quarters · filed 2023-08-03 | $6.67M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $1.78M 10-Q · filed 2023-05-04 | $3.60M derived: sum of 2 quarters · filed 2023-05-04 | $5.32M derived: sum of 3 quarters · filed 2023-05-04 | $7.49M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $3.54M derived: sum of 2 quarters · filed 2023-03-09 | $5.71M derived: sum of 3 quarters · filed 2023-03-09 | $7.01M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $1.72M 10-Q · filed 2022-11-10 | $3.89M derived: sum of 2 quarters · filed 2022-11-10 | $5.19M 10-Q · filed 2022-11-10 | $6.82M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $2.17M 10-Q · filed 2022-08-05 | $3.47M 10-Q · filed 2022-08-05 | $5.10M derived: sum of 3 quarters · filed 2022-08-05 | $6.85M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $1.29M 10-Q · filed 2022-05-05 | $2.92M derived: sum of 2 quarters · filed 2022-05-05 | $4.68M derived: sum of 3 quarters · filed 2022-05-05 | $6.42M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $3.39M derived: sum of 2 quarters · filed 2022-03-17 | $5.13M derived: sum of 3 quarters · filed 2022-03-17 | $7.08M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $1.76M 10-Q · filed 2021-10-28 | $3.50M derived: sum of 2 quarters · filed 2021-10-28 | $5.45M 10-Q · filed 2021-10-28 | $7.40M derived: sum of 4 quarters · filed 2021-10-28 | |
| 2020-06-30 | $1.74M 10-Q · filed 2021-08-05 | $3.70M 10-Q · filed 2021-08-05 | $5.64M derived: sum of 3 quarters · filed 2021-08-05 | $7.80M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $1.95M 10-Q · filed 2021-05-06 | $3.90M derived: sum of 2 quarters · filed 2021-05-06 | $6.06M derived: sum of 3 quarters · filed 2021-05-06 | $8.15M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $4.10M derived: sum of 2 quarters · filed 2021-03-11 | $6.20M derived: sum of 3 quarters · filed 2021-03-11 | $8.08M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $2.15M 10-Q · filed 2020-11-05 | $4.25M derived: sum of 2 quarters · filed 2020-11-05 | $6.13M 10-Q · filed 2020-11-05 | $7.15M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $2.09M 10-Q · filed 2020-08-06 | $3.98M 10-Q · filed 2020-08-06 | $5.00M derived: sum of 3 quarters · filed 2020-08-06 | $6.27M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $1.89M 10-Q · filed 2020-05-07 | $2.90M derived: sum of 2 quarters · filed 2020-05-07 | $4.18M derived: sum of 3 quarters · filed 2020-05-07 | $5.16M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.29M derived: sum of 2 quarters · filed 2020-03-12 | $3.28M derived: sum of 3 quarters · filed 2020-03-12 | $4.14M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $1.27M 10-Q · filed 2019-11-07 | $2.26M derived: sum of 2 quarters · filed 2019-11-07 | $3.13M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $984.78K 10-Q · filed 2019-08-09 | $1.85M 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $868.41K 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $2.71M 10-K · filed 2019-03-08 | ||||
| 2016-12-31 | $2.76M 10-K · filed 2018-03-29 | ||||
| 2015-12-31 | $2.19M 10-K · filed 2017-03-30 | ||||
| 2015-03-31 | $640.07K 10-Q · filed 2015-05-14 | $1.11M derived: sum of 2 quarters · filed 2016-03-30 | $1.56M derived: sum of 3 quarters · filed 2016-03-30 | $2.31M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-12-31 | $465.18K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $922.97K derived: sum of 2 quarters · filed 2016-03-30 | $1.67M derived: sum of 3 quarters · filed 2016-03-30 | $2.04M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $457.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $1.21M derived: sum of 2 quarters · filed 2014-11-12 | $1.57M 10-Q · filed 2014-11-12 | ||
| 2014-06-30 | $748.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.11M 10-Q · filed 2014-08-07 | |||
| 2014-03-31 | $365.69K 10-Q · filed 2014-06-11 | ||||
| 2013-12-31 | $1.70M 10-K · filed 2015-03-23 | ||||
| 2012-12-31 | $84.40K 10-Q · filed 2014-06-11 | ||||
| 2011-12-31 | $49.59K 10-Q · filed 2014-06-11 | ||||
| 2010-12-31 | $40.21K 10-Q · filed 2014-06-11 | ||||
| 2009-12-31 | $23.64K 10-Q · filed 2014-06-11 | ||||
| 2008-12-31 | $15.44K 10-Q · filed 2014-06-11 | ||||
| 2007-12-31 | $50.00 10-Q · filed 2014-06-11 | ||||
| 2006-12-31 | $50.00 10-Q · filed 2014-06-11 | ||||
| 2005-12-31 | $294.00 10-Q · filed 2014-06-11 | ||||
| 2004-12-31 | $269.00 10-Q · filed 2014-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |